# Next-generation KRAS G12C inhibitor improves survival in lung cancer

Source: [Medical research : nature.com subject feeds](https://www.nature.com/articles/d41591-026-00057-9) · 2026-11-10 · Medicine
Page: https://themorning.science/story/next-generation-kras-g12c-inhibitor-improves-survival-in-lung-cancer-b6ede287b2d0c2da
Kind: research · Impact: medium

## In brief

- A next-generation KRAS G12C inhibitor is reported to improve survival in lung cancer.
- Only the headline was available; the source has no summary, so no trial details are known.

## Why it matters

It reports a survival benefit from a targeted KRAS G12C drug, which is relevant to lung cancer treatment research.

## Coverage

- [Next-generation KRAS G12C inhibitor improves survival in lung cancer](https://www.nature.com/articles/d41591-026-00057-9) — Medical research : nature.com subject feeds, 2026-11-10

Tags: kras, lung cancer, targeted therapy, oncology

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science